PharmaTher (PHRRF) Breaks Above Resistance.
We're now up 325% in just Under a Year. Last "big" News was Receiving a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)...
Psycheceutial Biosciences (BWVI) Listed on WeFunder!
Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated.
Imagine the benefits of psychedelics, without hallucinating!
Our Favorite small Psychedelic company Psycheceutical Bioscience is using...
Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.
Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003...
Psychedelics CURED My Alcoholism
RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober.
Psychedelics CURED My Alcoholism—News Anchor Jon Kostakopoulos / Apollo Pact CEO
https://youtu.be/ghqY7s6UweU?si=-a2tuAGflKfLKI_j
https://youtu.be/fZzJB_UJ1X8?si=CsjSUacJ1qItKVyN
Participant On Life-Changing Sobriety...
ClearMind’s (CMND) MEAI and Reducing Alcohol Use.
Amazing New Technologies Keep Popping up.
We love when this happens during Sector Bear Markets, which Psychedelics have clearly been in. Amazing technology can be...
Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction
“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”
Known as the “Psychedelic Concierge...
Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.
Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
Here's the filing, end of transmission. As we have nothing else to add. AKA...
Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?
A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice
Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery...
COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement
Transaction led by healthcare specialist investors, TCGX and Aisling Capital
$125 million financing upfront with up to an additional $160 million tied to exercise of...
Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.
Cohen Psychedelic Research & Health Initiative
Cohen Foundation Awards $5 Million for MDMA Therapy Approval
Millions of Americans suffer from depression, anxiety, addiction, post-traumatic stress disorder...
Latest article
Latest Research Report: $20 Price Target from Greenridge Global.
Here are four research reports below to peruse, all with price targets $20.00 or more...
While we don't issue price targets, it's comforting to see...
Three More Companies Suspended by SEC!
Millions of Investor's Dollars are Being Trapped.
These three companies had a combined market cap of $563 million at the time they were halted, whose...
AI Data Center Short – Jim Chanos
“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls...
